Literature DB >> 8959582

Efficient fixation procedure of human leukemia cells in sulforhodamine B cytotoxicity assay.

H M Kim1, S B Han, M S Kim, J S Kang, G T Oh, D H Hong.   

Abstract

The fixation procedures in sulforhodamine B (SRB) assay for human leukemia cells were modified to produce more reliable results. It was found that the concentration of the fixative agent, trichloroacetic acid (TCA), was critical in the selective fixation of cellular protein. While a TCA solution of 80% fixed both cells and serum proteins, a 50% solution fixed only cells with a very low interference of the serum proteins. Accordingly, we selected 50% TCA as a fixative agent which made the final absorbance of the SRB assay to be exactly matched to the cell density with a small deviation and a low background. Besides the change of TCA concentration, a precentifugation of microplate just before fixation also improved the previous assay procedures in the two points of view. The 2-h standing step was simply substituted for only 1 min of centrifugation. Both the rapid and slow application of TCA solution in fixation produced the same extents of fixation. In an actual application, these two kinds of modifications in the previous SRB assay procedure were also proved to be effective in the determination of cytotoxicities of doxorubicin by using human leukemias.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959582     DOI: 10.1016/s1056-8719(96)00113-x

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  5 in total

1.  Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.

Authors:  Robin E Norris; Jane E Minturn; Garrett M Brodeur; John M Maris; Peter C Adamson
Journal:  Cancer Chemother Pharmacol       Date:  2011-04-12       Impact factor: 3.333

2.  A Simple Microplate Assay for Reactive Oxygen Species Generation and Rapid Cellular Protein Normalization.

Authors:  Neville S Ng; Lezanne Ooi
Journal:  Bio Protoc       Date:  2021-01-05

3.  Anti-melanogenic property of geoditin A in murine B16 melanoma cells.

Authors:  Florence W K Cheung; Jia Guo; Yick-Hin Ling; Chun-Tao Che; Wing-Keung Liu
Journal:  Mar Drugs       Date:  2012-02-16       Impact factor: 6.085

4.  Neutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells.

Authors:  Bonggoo Park; Yong-Moon Lee; Jae-Sung Kim; Youl Her; Ju Hee Kang; Seung-Hyun Oh; Hwan-Mook Kim
Journal:  BMC Complement Altern Med       Date:  2013-07-27       Impact factor: 3.659

5.  Metabolic adaptation to chronic inhibition of mitochondrial protein synthesis in acute myeloid leukemia cells.

Authors:  Bozhena Jhas; Shrivani Sriskanthadevan; Marko Skrtic; Mahadeo A Sukhai; Veronique Voisin; Yulia Jitkova; Marcela Gronda; Rose Hurren; Rob C Laister; Gary D Bader; Mark D Minden; Aaron D Schimmer
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.